Stay updated on Brentuximab Vedotin Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The record for the completed Phase 2 trial of brentuximab vedotin with pembrolizumab is now displayed, with study design, eligibility criteria, outcomes, participating locations, and data-sharing details.
    Difference
    85%
    Check dated 2026-10-24T14:50:30.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision indicator changes from v3.7.1 to v3.7.2 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:42:10.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:39:00.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    A new revision tag Revision: v3.7.0 is shown, and a large set of footer-related and sponsor/data-sharing texts is removed, including contact prompts and IPD sharing details. This changes the visible footer content and disclosure elements while leaving the core study information intact.
    Difference
    17%
    Check dated 2026-09-19T19:10:41.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous v3.6.5. This indicates a minor maintenance update to the site’s underlying system rather than changes to study information or presentation.
    Difference
    0.0%
    Check dated 2026-08-29T20:17:33.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.5, replacing the previous v3.6.4. This update reflects a new published revision of the page without altering the study information shown.
    Difference
    0.0%
    Check dated 2026-08-08T20:13:43.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.